Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of ovarian cancer cells treated by Paeonol

ABSTRACT: RNA sequencing of ovarian cancer cells treated by Paeonol

PROVIDER: PRJNA802126 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17832111_1.fastq.gz	Fastqsanger.gz
	SRR17832111_2.fastq.gz	Fastqsanger.gz
	SRR17832112_1.fastq.gz	Fastqsanger.gz
	SRR17832112_2.fastq.gz	Fastqsanger.gz
	SRR17832113_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNA sequencing of silica gel-immobilized and cisplatin-treated ovarian cancer cells

Project description:RNA sequencing of silica gel-immobilized and cisplatin-treated ovarian cancer cells

| PRJNA603090 | ENA

RNA sequencing of silica gel-immobilized and cisplatin-treated ovarian cancer cells

Project description:This study aimed to look at the signaling response of ovarian cancer cells to physical confinement in silica gels for 24 and 72 hr relative to standard culture control cells; the study also investigated transcriptomes of ovarian cancer cells surviving physical confinement and later extracted from silica gels and compared signaling to that of ovarian cancer cells surviving cisplatin drug treatment

2020-07-07 | GSE144232 | GEO

RNA sequencing of HJURP silencing in ovarian cancer cells

Project description:RNA sequencing of HJURP silencing in ovarian cancer cells

| PRJNA787567 | ENA

Profiling of differential RNAs in alpha amanitin treated SORBS2-depleted ovarian cancer cells and control-treated SORBS2-depleted

Project description:In this study, we examined the differential RNA profile of alpha amanitin-treated SORBS2-depleted ovarian cancer cells compared with control-treated SORBS2-depleted cells

2018-02-20 | GSE101595 | GEO

RNA sequencing (RNA-seq) of PQBP1 knockdown in ovarian cancer cells

Project description:RNA sequencing (RNA-seq) of PQBP1 knockdown in ovarian cancer cells

| PRJNA924813 | ENA

transcriptome analysis for luteolin or siVRK1 treated ovarian cancer cells

Project description:To investigate the function of Luteolin and siVRK1 on ovarian cancer, we use A2780 and ES2 cell lines treated with siCtrl, siVRK1, DMSO and luteolin to do the experiment. We then performed gene expression profiling analysis using data obtained from RNA-seq .

2022-09-07 | GSE212598 | GEO

HMGB1 interactome in prostate and ovarian cancer cells treated with cisplatin

Project description:Cisplatin is used in chemotherapy of prostate, ovary and other cancer types but unfortunately the efficiency of cisplatin treatment is frequently hampered by acquired resistance. The cytotoxic effect of cisplatin has been attributed to its binding to DNA. HMGB1 is able to bind to cisplatin-DNA adducts with high affinity and its expression levels are associated with cisplatin resistance. This study reports the interactome of HMGB1 in prostate and ovarian cancer cells treated with cisplatin.

2021-11-01 | PXD026309 | Pride

Identification of differentially expressed gene signature in ITLN1-treated ovarian cancer cells

Project description:Microarray analysis was used to identify differentially expressed gene signature in ovarian cancer A224 cells treated with recombinant human ITLN1 protein. MMP1 was found to be significantly upregulated in ITLN1-treated A224 cells. Further studies revealed that MMP1 is an important mediator for the ITLN1 suppression of ovarian cancer cell motility and invasion potential.

2019-09-20 | GSE120245 | GEO

High-throughout sequencing of ovarian cancer cells treated with TMPyP4 and H2O2

Project description:High-throughout sequencing of ovarian cancer cells treated with TMPyP4 and H2O2

| PRJNA1090047 | ENA

High-throughout sequencing of ovarian cancer cells treated with Annonacin and Carboplation

Project description:High-throughout sequencing of ovarian cancer cells treated with Annonacin and Carboplation

| PRJNA1195834 | ENA